CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Tenofovir disoproxil fumarate (TDF) versus emtricitabine plus TDF (FTC/TDF) for treatment of chronic hepatitis B (CHB) in patients with persistent viral replication receiving adefovir dipivoxi
DOI 10.1055/s-0029-1241401
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Berg, B Möller, G Gerken, R Zachoval, U Spengler, H Hartmann, A Snow-Lampart, D Oldach, J Sorbel, K Borroto-Esoda, D Frederick, F Rousseau
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: This trial compared TDF monotherapy versus combination FTC/TDF therapy in CHB patients who had incomplete virologic response after receiving adefovir dipivoxil (ADV) for at least 6 months. In both blinded treatment arms, patients were permitted to change to open-label FTC/TDF after 24 weeks (W) if persistent viremia >400 copies/mL was confirmed. Methodology: Entry criteria and baseline demographics/dis…
Zitieren
Zitierempfehlung
T Berg, B Möller, G Gerken, R Zachoval, U Spengler, H Hartmann, A Snow-Lampart, D Oldach, J Sorbel, K Borroto-Esoda, D Frederick, F Rousseau (2009) Tenofovir disoproxil fumarate (TDF) versus emtricitabine plus TDF (FTC/TDF) for treatment of chronic hepatitis B (CHB) in patients with persistent viral replication receiving adefovir dipivoxi. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0029-1241401
Mit CareLit weiterarbeiten